$ORMP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ORAMED PHARMACEUTICALS INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ORAMED PHARMACEUTICALS INC.. Get notifications about new insider transactions in ORAMED PHARMACEUTICALS INC. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 16 2013 | IGVL | ORAMED PHARMACEUTI ... | Hexter Joshua | Chief Operating Off ... | Option Exercise | A | 7.88 | 100,800 | 794,304 | 100,800 | |
| Feb 11 2013 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Option Exercise | A | 6.00 | 6,373 | 38,238 | 6,373 | |
| Feb 11 2013 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Grant | A | 0.00 | 12,745 | 0 | 243,000 | 230.3 K to 243 K (+5.54 %) |
| Dec 26 2012 | IGVL | ORAMED PHARMACEUTI ... | OSTROV GERALD M | Director | Option Exercise | A | 0.50 | 240,000 | 120,000 | 240,000 | |
| Nov 06 2012 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Option Exercise | A | 0.50 | 67,568 | 33,784 | 67,568 | |
| Nov 06 2012 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Option Exercise | A | 0.50 | 135,135 | 67,568 | 135,135 | |
| Nov 06 2012 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Grant | A | 0.27 | 135,135 | 36,716 | 2,763,055 | 2.6 M to 2.8 M (+5.14 %) |
| Nov 06 2012 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Grant | A | 0.27 | 270,270 | 73,432 | 2,627,920 | 2.4 M to 2.6 M (+11.46 %) |
| Dec 13 2012 | IGVL | ORAMED PHARMACEUTI ... | REGALS CAPITAL MANAGEMENT LP | 10% Owner | Option Exercise | P | 0.31 | 3,485,500 | 1,093,750 | 3,485,500 | |
| Dec 13 2012 | IGVL | ORAMED PHARMACEUTI ... | REGALS CAPITAL MANAGEMENT LP | 10% Owner | Option Exercise | H | 0.31 | 3,485,500 | 1,093,750 | 0 | |
| Dec 13 2012 | IGVL | ORAMED PHARMACEUTI ... | REGALS CAPITAL MANAGEMENT LP | 10% Owner | Option Exercise | P | 0.31 | 1,351,352 | 424,054 | 1,351,352 | |
| Dec 13 2012 | IGVL | ORAMED PHARMACEUTI ... | REGALS CAPITAL MANAGEMENT LP | 10% Owner | Option Exercise | H | 0.50 | 1,351,352 | 675,676 | 0 | |
| Dec 13 2012 | IGVL | ORAMED PHARMACEUTI ... | REGALS CAPITAL MANAGEMENT LP | 10% Owner | Option Exercise | P | 0.31 | 202,703 | 63,608 | 202,703 | |
| Dec 13 2012 | IGVL | ORAMED PHARMACEUTI ... | REGALS CAPITAL MANAGEMENT LP | 10% Owner | Option Exercise | H | 0.50 | 202,703 | 101,352 | 0 | |
| Dec 13 2012 | IGVL | ORAMED PHARMACEUTI ... | REGALS CAPITAL MANAGEMENT LP | 10% Owner | Option Exercise | P | 0.60 | 1,647,722 | 988,633 | 1,647,722 | |
| Nov 23 2012 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Option Exercise | A | 0.00 | 3,361,360 | 3,361 | 3,361,360 | |
| Nov 23 2012 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Option Exercise | D | 0.00 | 3,361,360 | 3,361 | 0 | |
| Nov 23 2012 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Option Exercise | A | 0.00 | 3,361,360 | 3,361 | 3,361,360 | |
| Nov 06 2012 | IGVL | ORAMED PHARMACEUTI ... | REGALS CAPITAL MANAGEMENT LP | 10% Owner | Option Exercise | P | 0.50 | 202,703 | 101,352 | 202,703 | |
| Nov 06 2012 | IGVL | ORAMED PHARMACEUTI ... | REGALS CAPITAL MANAGEMENT LP | 10% Owner | Buy | P | 0.00 | 405,405 | 0 | 9,127,670 | 8.7 M to 9.1 M (+4.65 %) |
| Aug 09 2012 | IGVL | ORAMED PHARMACEUTI ... | Berelowitz Michael | Director | Option Exercise | A | 0.34 | 40,000 | 13,600 | 340,000 | |
| Aug 09 2012 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Option Exercise | A | 0.34 | 240,000 | 81,600 | 868,125 | |
| Aug 09 2012 | IGVL | ORAMED PHARMACEUTI ... | Zommer Yifat Hen | CFO, TREASURER AND ... | Option Exercise | A | 0.34 | 609,000 | 207,060 | 1,009,000 | |
| Aug 09 2012 | IGVL | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Option Exercise | A | 0.34 | 864,000 | 293,760 | 2,592,000 | |
| Aug 09 2012 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Technology Of ... | Option Exercise | A | 0.34 | 864,000 | 293,760 | 5,953,360 | |
| Aug 09 2012 | IGVL | ORAMED PHARMACEUTI ... | JACOB HAROLD | Director | Option Exercise | A | 0.34 | 240,000 | 81,600 | 540,000 | |
| Oct 06 2011 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Option Exercise | A | 0.50 | 328,125 | 164,063 | 328,125 | |
| Oct 06 2011 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Buy | P | 0.32 | 937,500 | 300,000 | 937,500 | 0 to 937.5 K |
| Sep 28 2011 | IGVL | ORAMED PHARMACEUTI ... | Bronfeld Zeev | 10% Owner | Sell | S | 0.28 | 350,000 | 98,000 | 5,808,517 | 6.2 M to 5.8 M (-5.68 %) |
| Apr 04 2011 | IGVL | ORAMED PHARMACEUTI ... | Bronfeld Zeev | 10% Owner | Option Exercise | J | 0.50 | 273,438 | 136,719 | 273,438 | |
| Apr 04 2011 | IGVL | ORAMED PHARMACEUTI ... | Bronfeld Zeev | 10% Owner | Buy | P | 0.32 | 781,250 | 250,000 | 7,213,205 | 6.4 M to 7.2 M (+12.15 %) |
| Jul 12 2010 | IGVL | ORAMED PHARMACEUTI ... | Berelowitz Michael | Director | Option Exercise | A | 0.48 | 300,000 | 144,000 | 300,000 | |
| May 03 2010 | IGVL | ORAMED PHARMACEUTI ... | KIDRON NADAV | CEO | Option Exercise | A | 0.49 | 864,000 | 423,360 | 12,949,735 | |
| May 03 2010 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Chief Medical &Tech ... | Option Exercise | A | 0.49 | 864,000 | 423,360 | 5,939,360 | |
| Jun 08 2009 | IGVL | ORAMED PHARMACEUTI ... | Zommer Yifat Hen | CFO, TREASURER AND ... | Option Exercise | A | 0.47 | 400,000 | 188,000 | 400,000 | |
| Jan 13 2009 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Option Exercise | A | 0.43 | 300,000 | 129,000 | 300,000 | |
| Jan 13 2009 | IGVL | ORAMED PHARMACEUTI ... | JACOB HAROLD | Director | Option Exercise | A | 0.43 | 300,000 | 129,000 | 300,000 | |
| Oct 16 2008 | IGVL | ORAMED PHARMACEUTI ... | ORLEV CHAIME | CFO, Treasurer and ... | Option Exercise | A | 0.47 | 828,000 | 389,160 | 828,000 | |
| May 09 2008 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | See Remarks | Option Exercise | A | 0.54 | 864,000 | 466,560 | 864,000 | |
| May 09 2008 | IGVL | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Option Exercise | A | 0.54 | 864,000 | 466,560 | 864,000 | |
| Jan 17 2008 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Buy | P | 0.25 | 5,000 | 1,250 | 3,557,650 | 3.6 M to 3.6 M (+0.14 %) |
| Jan 17 2008 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Buy | P | 0.25 | 15,650 | 3,913 | 3,552,650 | 3.5 M to 3.6 M (+0.44 %) |
| Jan 09 2008 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Buy | P | 0.30 | 22,840 | 6,852 | 3,537,000 | 3.5 M to 3.5 M (+0.65 %) |
| Jan 07 2008 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Buy | P | 0.30 | 48,000 | 14,400 | 3,514,160 | 3.5 M to 3.5 M (+1.38 %) |
| Jan 03 2008 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Buy | P | 0.30 | 121,160 | 35,948 | 3,466,160 | 3.3 M to 3.5 M (+3.62 %) |
| Jan 03 2008 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Buy | P | 0.24 | 85,000 | 20,247 | 3,345,000 | 3.3 M to 3.3 M (+2.61 %) |
| Jan 03 2008 | IGVL | ORAMED PHARMACEUTI ... | Sank Leonard | Director | Buy | P | 0.25 | 10,000 | 2,500 | 3,260,000 | 3.3 M to 3.3 M (+0.31 %) |
| Aug 08 2007 | IGVL | ORAMED PHARMACEUTI ... | Kidron Miriam | Director | Option Exercise | A | 0.45 | 850,000 | 382,500 | 850,000 | |
| Aug 03 2007 | IGVL | ORAMED PHARMACEUTI ... | KIDRON NADAV | President & CEO | Option Exercise | A | 0.45 | 850,000 | 382,500 | 850,000 | |
| Jun 10 2004 | IGVL | ORAMED PHARMACEUTI ... | Young Michael | Sell | S | 0.00 | 6,000,000 | 19,800 | 0 | 6 M to 0 (-100.00 %) |